Thomas J Rutkoski Selected Research

Thomas J Rutkoski Research Topics

9	Neoplasms (Cancer) 01/2019 - 11/2005
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2017 - 04/2011
2	Lung Neoplasms (Lung Cancer) 01/2013 - 09/2010
2	Malignant Mesothelioma 06/2008 - 11/2005
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2019
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2017
1	Brain Neoplasms (Brain Tumor) 09/2015
1	Neoplasm Metastasis (Metastasis) 09/2015
1	Melanoma (Melanoma, Malignant) 05/2015
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2011
1	Leukemia 04/2011
1	Crohn Disease (Crohn's Disease) 05/2005
1	Rheumatoid Arthritis 05/2005

4	Phosphotransferases (Kinase)IBA 01/2019 - 04/2011
4	Ribonucleases (Ribonuclease)IBA 01/2013 - 06/2008
2	Tyrosine Kinase InhibitorsIBA 01/2017 - 04/2011
2	LY3009120IBA 09/2015 - 05/2015
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2013 - 09/2010
2	Pancreatic Ribonuclease (Ribonuclease A)IBA 09/2010 - 11/2005
1	Pharmaceutical PreparationsIBA 01/2019
1	ripretinibIBA 01/2019
1	Adenosine (Adenocard)FDA LinkGeneric 01/2017
1	rebastinibIBA 01/2017
1	Protein Isoforms (Isoforms)IBA 09/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2015
1	dabrafenibIBA 05/2015
1	VemurafenibIBA 05/2015
1	Urea (Carbamide)FDA LinkGeneric 05/2015
1	Ethylene Glycol (Monoethylene Glycol)IBA 01/2013
1	DCC-2036IBA 04/2011
1	Arginine (L-Arginine)FDA Link 10/2007
1	ranpirnase (Pannon)IBA 11/2005
1	Infliximab (Remicade)FDA Link 05/2005
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2005
1	Immunoglobulin G (IgG)IBA 05/2005
1	Monoclonal AntibodiesIBA 05/2005

1	Oral Administration 09/2015